HOLX Logo

Hologic Inc (HOLX) Stock Forecast & Price Prediction

Live HOLX Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NASDAQ | Healthcare | Medical Instruments & Supplies

$63.24

-0.38 (-0.60%)

12 Month Price Forecast For HOLX

$63.24
Current Price
$14.26B
Market Cap
21 Ratings
Buy 7
Hold 14
Sell 0
Wall St Analyst Ratings

Distance to HOLX Price Forecasts

+50.2%
To High Target of $95.00
+26.5%
To Median Target of $80.00
+10.7%
To Low Target of $70.00

HOLX Price Momentum

-2.1%
1 Week Change
-8.0%
1 Month Change
-14.3%
1 Year Change
-12.3%
Year-to-Date Change
-25.3%
From 52W High of $84.67
+0.5%
From 52W Low of $62.94

๐Ÿค” Considering Hologic (HOLX)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 15, 2025 3:27 AM UTC

HOLX Analyst Ratings & Price Targets

Based on our analysis of 27 Wall Street analysts, HOLX has a neutral consensus with a median price target of $80.00 (ranging from $70.00 to $95.00). The overall analyst rating is Buy (7.0/10). Currently trading at $63.24, the median forecast implies a 26.5% upside. This outlook is supported by 7 Buy, 14 Hold, and 0 Sell ratings.

The most optimistic forecast comes from Andrew Cooper at Raymond James, projecting a 50.2% upside. Conversely, the most conservative target is provided by Vijay Kumar at Evercore ISI Group, suggesting a 10.7% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

HOLX Analyst Consensus

7
Buy
14
Hold
0
Sell

HOLX Price Target Range

Low
$70.00
Average
$80.00
High
$95.00
Current: $63.24

Latest HOLX Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for HOLX.

Date Firm Analyst Rating Change Price Target
Feb 6, 2025 Stephens & Co. Mason Carrico Overweight Reiterates $84.00
Feb 6, 2025 Raymond James Andrew Cooper Outperform Reiterates $90.00
Feb 6, 2025 Needham Mike Matson Hold Reiterates $0.00
Feb 6, 2025 Leerink Partners Puneet Souda Market Perform Downgrade $75.00
Feb 6, 2025 Evercore ISI Group Vijay Kumar In-Line Maintains $73.00
Feb 6, 2025 RBC Capital Conor McNamara Sector Perform Maintains $85.00
Feb 3, 2025 Needham Mike Matson Hold Downgrade $90.00
Jan 13, 2025 Morgan Stanley Tejas Savant Equal-Weight Maintains $82.00
Jan 13, 2025 Needham Mike Matson Buy Reiterates $90.00
Dec 19, 2024 Needham Mike Matson Buy Reiterates $90.00
Dec 13, 2024 Wolfe Research Doug Schenkel Peer Perform Initiates $0.00
Dec 10, 2024 Jefferies Tycho Peterson Hold Initiates $85.00
Nov 5, 2024 JP Morgan Casey Woodring Overweight Maintains $94.00
Nov 5, 2024 Mizuho Anthony Petrone Outperform Maintains $87.00
Nov 5, 2024 Raymond James Andrew Cooper Outperform Maintains $95.00
Nov 5, 2024 UBS Elizabeth Garcia Neutral Maintains $90.00
Nov 5, 2024 RBC Capital Conor McNamara Sector Perform Maintains $89.00
Oct 15, 2024 Needham Mike Matson Buy Reiterates $90.00
Oct 8, 2024 Leerink Partners Puneet Souda Outperform Maintains $90.00
Oct 4, 2024 Mizuho Anthony Petrone Outperform Maintains $90.00

Stocks Similar to Hologic Inc

The following stocks are similar to Hologic based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Hologic Inc (HOLX) Financial Data

Hologic Inc has a market capitalization of $14.26B with a P/E ratio of 20.1x. The company generates $3.99B in trailing twelve-month revenue with a 17.6% profit margin.

Revenue growth is +4.5% quarter-over-quarter, while maintaining an operating margin of +24.4% and return on equity of +13.8%.

Valuation Metrics

Market Cap $14.26B
Enterprise Value $17.92B
P/E Ratio 20.1x
PEG Ratio 13.5x
Price/Sales 3.6x

Growth & Margins

Revenue Growth (YoY) +4.5%
Gross Margin +56.8%
Operating Margin +24.4%
Net Margin +17.6%
EPS Growth +97.1%

Financial Health

Cash/Price Ratio +14.7%
Current Ratio 4.0x
Debt/Equity 49.4x
ROE +13.8%
ROA +6.4%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Hologic Inc logo

Hologic Inc (HOLX) Company Overview

About Hologic Inc

What They Do

Develops diagnostic and surgical products for women's health.

Business Model

Hologic, Inc. generates revenue through the development, manufacturing, and supply of a diverse range of medical products focused on women's health. The company operates across four segmentsโ€”Diagnostics, Breast Health, GYN Surgical, and Skeletal Healthโ€”offering solutions such as molecular diagnostic assays, breast cancer care technologies, and surgical systems. Their products are sold through direct sales, independent distributors, and sales representatives, ensuring a broad market reach.

Additional Information

Founded in 1985 and based in Marlborough, Massachusetts, Hologic, Inc. is committed to early detection and treatment in women's health care. The company offers innovative solutions, including advanced imaging systems and minimally invasive surgical products, positioning itself as a key player in the healthcare industry.

Company Information

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

6,990

CEO

Mr. Stephen P. MacMillan

Country

United States

IPO Year

1990

Hologic Inc (HOLX) Latest News & Analysis

HOLX stock latest news image
Quick Summary

Hologic (HOLX) is currently a highly monitored stock by Zacks.com users, indicating increased investor interest and potential future developments to watch.

Why It Matters

Increased attention from Zacks.com users suggests heightened investor interest in Hologic (HOLX), potentially impacting its stock performance and market sentiment.

Source: Zacks Investment Research
Market Sentiment: Positive
HOLX stock latest news image
Quick Summary

Hologic's overseas revenue trends are impacting Wall Street forecasts and the stock's future outlook. Investors should monitor these developments for potential effects on performance.

Why It Matters

Hologic's overseas revenue trends can directly influence earnings forecasts and stock valuation, impacting investment decisions and market sentiment regarding future growth.

Source: Zacks Investment Research
Market Sentiment: Neutral
HOLX stock latest news image
Quick Summary

Hologic's strong performance in molecular diagnostics boosts investor optimism, but a weak macroeconomic outlook poses potential concerns.

Why It Matters

Hologic's strong molecular diagnostics performance boosts confidence, while economic headwinds may impact overall growth, affecting investment decisions and market sentiment.

Source: Zacks Investment Research
Market Sentiment: Positive
HOLX stock latest news image
Quick Summary

Hologic's Surgical business is experiencing strong growth by expanding its technologies into new global markets.

Why It Matters

Hologic's Surgical business growth signals increased revenue potential and market expansion, which may enhance overall company valuation and attract investment interest.

Source: Zacks Investment Research
Market Sentiment: Positive
HOLX stock latest news image
Quick Summary

Hologic reduced its fiscal 2025 revenue forecast due to declining breast health product sales, resulting in a 5% drop in share price after the announcement.

Why It Matters

Hologic's lowered revenue forecast indicates declining demand, negatively impacting future earnings and investor sentiment, leading to a 5% drop in share price.

Source: Reuters
Market Sentiment: Negative
HOLX stock latest news image
Quick Summary

Hologic, Inc. (NASDAQ: HOLX) will hold its Q1 2025 Earnings Conference Call on February 5, 2025, at 4:30 PM ET, featuring key executives and analysts from various firms.

Why It Matters

Hologic's Q1 2025 earnings call indicates upcoming financial performance insights, which can influence stock valuations and investor sentiment.

Source: Seeking Alpha
Market Sentiment: Neutral

Frequently Asked Questions About HOLX Stock

What is Hologic Inc's (HOLX) stock forecast for 2025?

Based on our analysis of 27 Wall Street analysts, Hologic Inc (HOLX) has a median price target of $80.00. The highest price target is $95.00 and the lowest is $70.00.

Is HOLX stock a good investment in 2025?

According to current analyst ratings, HOLX has 7 Buy ratings, 14 Hold ratings, and 0 Sell ratings. The stock is currently trading at $63.24. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for HOLX stock?

Wall Street analysts predict HOLX stock could reach $80.00 in the next 12 months. This represents a 26.5% increase from the current price of $63.24. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Hologic Inc's business model?

Hologic, Inc. generates revenue through the development, manufacturing, and supply of a diverse range of medical products focused on women's health. The company operates across four segmentsโ€”Diagnostics, Breast Health, GYN Surgical, and Skeletal Healthโ€”offering solutions such as molecular diagnostic assays, breast cancer care technologies, and surgical systems. Their products are sold through direct sales, independent distributors, and sales representatives, ensuring a broad market reach.

What is the highest forecasted price for HOLX Hologic Inc?

The highest price target for HOLX is $95.00 from Andrew Cooper at Raymond James, which represents a 50.2% increase from the current price of $63.24.

What is the lowest forecasted price for HOLX Hologic Inc?

The lowest price target for HOLX is $70.00 from Vijay Kumar at Evercore ISI Group, which represents a 10.7% increase from the current price of $63.24.

What is the overall HOLX consensus from analysts for Hologic Inc?

The overall analyst consensus for HOLX is neutral. Out of 27 Wall Street analysts, 7 rate it as Buy, 14 as Hold, and 0 as Sell, with a median price target of $80.00.

How accurate are HOLX stock price projections?

Stock price projections, including those for Hologic Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.